Idiopathic Pulmonary HemosiderosisSymptoms, Doctors, Treatments, Advances & More
Idiopathic Pulmonary Hemosiderosis Overview
Learn About Idiopathic Pulmonary Hemosiderosis
- Idiopathic pulmonary hemosiderosis
- Siderosis
- Alveolar hypoventilation syndrome
- Hemosiderosis, pulmonary, with deficiency of gamma-a globulin
- Pulmonary hemosiderosis
Vince Lombardi Cancer Clinic
Demet Yasar is a Hematologist in Green Bay, Wisconsin. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS).
Abingdon Physician Partners - Regional Cancer Center At Johnston Memorial Hospital
. Dr. Davis is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, Thrombocytopenia, and Colorectal Cancer.
Abingdon Physician Partners - Regional Cancer Center At Johnston Memorial Hospital
Anthony DeSalvo, MD, believes the best care comes from both science and compassion, especially during life's most difficult moments. He chose to specialize in oncology because it's rapidly advancing field that allows him to support patients when they need it most. After an internal medicine rotation, he explored several career paths but felt a strong connection to oncology and the opportunity it provides to make a meaningful difference. Originally from upstate New York, Dr. DeSalvo first came to the Appalachian Highlands to attend Virginia Tech and fell in love with the region. He was drawn back by the honesty and faith of the people here. In his free time, he enjoys restoring his pre-Civil War farmhouse, hiking and swimming. Dr. Desalvo is rated as an Experienced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Childhood Iron Deficiency Anemia.
Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


